Economy & Markets
Thyroid medication recalled nationwide after tablets found to be 'superpotent': FDA
Vitruvias Therapeutics is recalling one lot of Thyroid Tablets, USP 30 mg, distributed nationwide after testing found the medication could be more potent than intended
Read more at FOX BIZ ›
Read the full story at
FOX BIZ
The Gadsden Report aggregates and summarises headlines. The reporting above belongs to FOX BIZ, and the link opens their page. This page exists so readers can find, share, and discuss the story here.